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Abstract
Introduction: Menstruation is commonly associated with migraine and irritable bowel but is rarely
correlated with angina or myocardial ischaemia. Only a small number of cases have been reported
suggesting a link between menstruation and myocardial ischaemic events.
Case presentation: A case of menstruation angina is reported in order to raise awareness of this
association. A 47-year-old South Asian woman presented with recurrent chest pains in a monthly
fashion coinciding with her menstruations. Each presentation was associated with troponin
elevation. Angioplasty failed to resolve her symptoms but she eventually responded to hormonal
therapy.
Conclusions: The possibility of menstruation angina should always be taken into account in any
female patients from puberty to menopause presenting with recurrent chest pains. This can allow an
earlier introduction of hormonal therapy to arrest further myocardial damage.
Introduction
While some live through menstrual cycles as part and
parcel of their lives, the cyclical fluctuation of sex
hormones disturbs the lives of many others. To date,
menstruation has established effects on migraine,
epilepsy, asthma, irritable bowel syndrome and
diabetes [1].
The few suffering from ‘menstruation angina’ or
‘catamenial angina’ may not have earned the attention
they deserve. Research into the relationship between
coronary events and menstrual cycles is still in its
infancy, but preliminary trials have so far shown
compelling evidence.
Case presentation
A 47-year-old South Asian woman presented with a
3-month history of recurrent left-sided chest pains. Initially,
her pains were non-exertional and were relieved by
massages and antacids. The onset of her pains usually
coincided with the second or third day of her menstruation
eachmonthandusuallylastedupto4days.Restsfrequently
eased her pains, hence she did not seek medical attention.
She eventually presented to our Emergency Department in
the fourth month. She had sudden onset sharp chest pain,
10/10 in intensity, which radiated up to her jaw and
travelled down to her arms. The pain was non-exertional
and sublingual nitrates did not help. She also complained
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presentation coincided with the second day of her
menstruation.
Aside from a raised Body Mass Index (BMI) of 37.2 and
anaemia, she did not have any other cardiac risk factors.
Her fasting blood glucose was 6.8 and she did not have a
history of ischaemic heart disease. These risk factors had
not changed over the last year.
Her menstrual periods were usually regular in interval and
she rarely suffered from menorrhagia. She had had two
myomectomies about 25 years ago. A fibroid of the size of
a 3-month-old foetus was discovered in a recent lapar-
otomy. She had three failed attempts of in-vitro fertiliza-
tion (IVF). There was no family history of ischaemic heart
disease or gynaecological conditions. She did not take any
medication on a regular basis.
On examination, she was found to have peripheral and
central cyanosis. There were no other relevant findings.
Her electrocardiogram showed ST-segment elevation and
Q waves in the anterior leads and ST-segment depression
in the inferior leads. This together with a rise in troponin
T and creatine kinase levels to 50ng/ml and 2045U/L,
respectively was suggestive of a ST segment elevation
myocardial infarction (STEMI). Other abnormalities in the
serum laboratory studies were a raised C-reactive protein
(CRP) of 70mg/L and haemoglobin of 9.2g/dL. She was
transfused with a unit of blood as a result. A coronary
angiogram revealed a left anterior descending (LAD) artery
occlusion. A stent was inserted.
Her chest pain recurred the following month, again
coinciding with her menstruation. The nature of her pain
in this admission was similar to that in her first admission
although it was reported to be milder in severity. Her
electrocardiogram this time showed ischaemic changes
only to the inferior region. Troponin T was elevated to
3.2ng/mL. Oestrogen and progesterone levels were con-
sistently normal to her phases in menstruation.
Given that the troponin level usually takes about 10 days
to decline to normality post-myocardial infarction, tropo-
nin detected in this second admission may be a misnomer
and may be attributed to the slow decline in troponin
from her first admission. In that case, the diagnosis in this
admission would be unstable angina rather than STEMI, as
per definition [2].
Although the failure of symptom resolution after angio-
plasty may indicate an early stent failure or incomplete
coronary revascularization, it could also indicate the
presence of another underlying pathology. Dynamic
obstructions due to intense focal spasm of arteries as
seen in Prinzmetal’s angina could also explain the
persistence of her symptoms. Coronary vasospasm itself
may also trigger a rise in troponin [3]. It was agreed at that
time that she should be managed conservatively but a
coronary angiogram should be repeated if her symptoms
changed in nature, character or frequency.
Monthly serial electrocardiograms were done. Ergonovine
or acetylcholine could be used to induce coronary
vasospasm during coronary angiography but was not
attempted due to safety concerns and lack of prognostic
values. A trial of luteinizing hormone releasing hormone
(LHRH) analogues in an attempt to induce early meno-
pause only brought limited benefit although she experi-
enced multiple relapses. While LHRH might be a choice to
halt menstruation, it does not stop the underlying cyclical
oestrogen decline. Instead, it completely removes
oestrogen.
Ultimately, hormonal replacement therapy (oestrogen
replacement) was used to address the cyclical oestrogen
decline with good response. Her symptoms largely
resolved in the subsequent 12 months, with only one
episode of repeat chest pain. An angiography performed
eventually showed patent arteries and stent. She was
planned to continue with antithrombotic modulation
(aspirin and clopidogrel) for her underlying atherosclero-
tic disease.
Discussion
Small guanosine triphosphate (GTP)-binding protein Rho
and its effector Rho-kinase play an important role in
smooth muscle contraction and actin cytoskeleton orga-
nization [4]. Porcine and human artery experiments in vivo
have demonstrated that Rho-kinase can induce inflamma-
tory atherosclerotic lesions and trigger coronary vasospas-
tic responses through inhibition of myosin light chain
phosphate [5]. On the other hand, long-term inhibition of
Rho-kinase can resolve coronary vasospastic activities [6].
At supraphysiological concentrations, oestrogen is known
to inhibit Rho-kinase mRNA expression in human
coronary vascular smooth muscle cells (VSMC) averting
vasospasm [7]. Acting through two receptors, a and b,
oestrogen is also known to inhibit the influx of
extracellular calcium into VSMC and to up-regulate genes
governing vasodilatory enzymes (that is to say, prostacy-
clin synthase and nitric oxide synthase) [8]. These
mechanisms will reduce vascular tone in the long term.
At physiological concentrations, oestrogen was shown to
cause rapid release of nitric oxide without any prerequisite
genetic alterations [9]. This, together with the cGMP-
mediated pathways, will open the calcium-activated
potassium channels relaxing smooth muscles [8].
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for nitric oxide synthase activity [10]. The variability in
number of a- and b-oestrogen receptors from person to
person may explain why some women are more prone to
heart disease than others.
The effects of oestrogen on blood vessels can be simplified
into rapid (non-genomic) effects and long-term (genomic)
effects as illustrated by Mendelsohn and Karas in Figure 1
[10]. Other long-term cardioprotective effects of oestrogen
including the acceleration in endothelial cell regeneration
post-vascular injury and the reduction in atherosclerosis
may be less relevant to the pathogenesis of menstruation
angina [11].
The physiological fluctuation in oestrogen and progester-
one levels occurs in a 28-day cycle in a pre-menopausal
woman. Oestrogen level is lowest in the menstrual phase
(Day 1–5) followed by a gradual rise peaking around Day
14 when ovulation occurs. Thereafter, oestrogen level tails
off making way for the next cycle.
It is known that post-menopausal women suffer from an
increased risk of atherosclerotic and vasospastic disorders
after losing oestrogen’s cardioprotective effects [6]. The
reduction in oestrogen level at the commencement of
each menstrual cycle in a premenopausal woman may
mimic the lack of oestrogen post-menopausal women
encounter. This coincides with a higher risk of coronary
events, as seen in our patient. In a study by Lloyd et al.,
all 10 young female participants developed 1-mm
ST-segment depression and chest pain quicker when
their oestrogen levels were lowest [12].
Clark et al. observed electrocardiogram changes in 12
healthy female volunteers in three phases: the menstrua-
tion (days 2–3), pre-ovulation (days 12–13) and post-
ovulation (day 19) phases [13]. Six of the volunteers
developed ST-segment depression in stress tests during the
menstruation and pre-ovulation phases or both, when
oestrogen levels were lowest. When progesterone levels
were highest at day 19, there were no greater electro-
cardiographic abnormalities.
Kawano et al. examined the effects of oestrogen on arterial
function and ischaemic symptoms in 10 women [14]. The
diameter and flow velocity in the brachial arteries were
presumed to reflect those of coronary arteries since they
have related endothelial functions [14]. Vasodilatation
was found to be greatest at mid-cycle when oestrogen
levels were high. When oestrogen levels were lowest in the
menstrual phase, the patients had more ischaemic events
with corresponding ST segment changes.
Failing all, vasospastic angina can be treated in isolation.
High doses of calcium antagonists and anti-alpha adre-
nergic drugs, such as guanethidine or clonidine, can
suppress persistent attacks [15]. The use of anti-oxidant
vitamins C and E may also improve endothelial function
and decrease vascular reactivity in vasospastic angina [15].
Rho-kinase inhibitor, still in its experimental stages, is
aimed at preventing VSMC-induced vasospasm [15].
Coronary bypass surgery may be indicated in patients with
obstructive coronary artery disease in addition to coronary
vasospasm as in this scenario. However, in our patient, it
may not be immediately necessary given that she has a
patent stent.
Conclusion
Laboratory and genetic studies have confirmed the
cardioprotective effects of oestrogen. To date, we only
have three notable trials to illustrate that angina can be set
off by diminished oestrogen levels during menstruation,
one of them accomplished almost two decades ago.
In years to come, more studies need to be conducted.
A substantial number of patients may be suffering from this
condition without our knowledge. Episodic chest pains if
mildmaybeovershadowedbymorecommonsymptomsof
menstruation as mentioned. Not until then may guidelines
be drawn to change our clinical practice in women’s health.
We should also bear in mind that, although episodic chest
pains in women may be attributed to cyclical oestrogen
Figure 1.
Direct effects of oestrogen on blood vessels.
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more common. Therefore, coronary angiography should
not be delayed in any case.
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